A bipartisan proposal to establish a therapeutic psilocybin program in New Mexico had an initial hearing before a Senate committee on Tuesday, with lawmakers voting unanimously to advance the bill.
Members of the Senate Tax, Business and Transportation Committee voted 10–0 in favor of SB 219, known as the Medical Psilocybin Act. If enacted, patients with certain qualifying conditions would be able access the psychedelic and use it under the guidance of a licensed healthcare provider.
Therapy would consist of a preparation session, an administration session and a follow-up integration session.
“Psilocybin in mushrooms is a natural substance that has been found…to be medically efficacious for a variety of treatments,” the measure’s lead sponsor Sen. Jeff Steinborn (D), told committee members at the hearing. “This bill seeks to create a very thoughtful, very specific, limited medical program that would be operated by the Department of Health.”
He added that the proposal “was developed every step along the way with consultation and participation from the Department of Health.”
Text of the measure says its purpose “is to allow the beneficial use of psilocybin in a regulated system for alleviating qualified medical conditions,” including major treatment-resistant depression, PTSD, substance use disorders and
Read full article on Marijuana Moment
